Drug Science publish regular articles that analyse developments in drug science and policy to highlight areas of improvement based on evidence

By Rayyan Zafar an Honorary Research Assistant for Drug Science Can a ‘double standard’ in paediatric medicine provide a framework to restructure repressive medical cannabis policies? In 2019, a drug called Zolgensma came to market. This drug used a particularly innovative gene therapy technique to treat infants suffering with an extremely…

Last month we asked for your stories, and we’re thrilled with the response we received. These provide us with valuable insights and snapshots into the experiences of our patients, both the benefits and the challenges. Thank you so much for submitting these, and we would love to gather more of these…

Statement from Drug Science regarding Project Twenty 21 and its official industry partners. For immediate release Drug Science would like to clarify the aims of the Project Twenty 21 initiative and who its industry partners are. This follows recent press release from Kanabo, announcing that it had signed its first UK…